BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11346378)

  • 21. Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child.
    Berman JL; Kashii S; Trachtman MS; Burde RM
    Ophthalmology; 1990 Dec; 97(12):1606-9. PubMed ID: 2087291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of primary Sjögren's syndrome with acute transverse myelopathy and polyneuropathy as the initial manifestations].
    Yanagihara C; Nakaji K; Nishimura Y
    Rinsho Shinkeigaku; 2001 Jan; 41(1):50-5. PubMed ID: 11433768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome.
    Tesar JT; McMillan V; Molina R; Armstrong J
    Am J Med; 1992 Jun; 92(6):686-92. PubMed ID: 1605151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral sequential optic neuropathy as the initial manifestation of Sjögren syndrome.
    Pournaras JA; Vaudaux JD; Borruat FX
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):337-9. PubMed ID: 17458808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor dominant neuropathy in Sjögren's syndrome: report of two cases.
    Mochizuki H; Kamakura K; Masaki T; Hirata A; Nakamura R; Motoyoshi K
    Intern Med; 2002 Feb; 41(2):142-6. PubMed ID: 11868603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myelopathy - Sjogren's syndrome association: analysis of clinical and radiological findings and clinical course].
    de Seze J; Stojkovic T; Hachulla E; Breteau G; Michon-Pasturel U; Mounier-Vehier F; Hatron PY; Vermersch P
    Rev Neurol (Paris); 2001 Jul; 157(6-7):669-78. PubMed ID: 11458186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
    Pericot I; Brieva L; Tintoré M; Río J; Sastre-Garriga J; Nos C; Montalban X
    Mult Scler; 2003 Jun; 9(3):256-9. PubMed ID: 12814172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of extraglandular manifestations of Sjögren's syndrome.
    Cheah TE; Jasmin R; Sockalingam S
    Int J Rheum Dis; 2012 Dec; 15(6):e156-8. PubMed ID: 23253245
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent longitudinally extensive transversal myelitis in a patient with Sjögren's syndrome.
    Sekarić J; Zivanović Z; Lucić-Prokin A; Kokai-Zekić T; Petrović K; Turkalj I; Jovin Z; Gvozdenović S
    Vojnosanit Pregl; 2013 Nov; 70(11):1056-8. PubMed ID: 24397203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transverse myelitis in systemic sclerosis.
    Torabi AM; Patel RK; Wolfe GI; Hughes CS; Mendelsohn DB; Trivedi JR
    Arch Neurol; 2004 Jan; 61(1):126-8. PubMed ID: 14732630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelopathy in primary Sjögren's syndrome: diagnostic and therapeutic aspects.
    Hermisson M; Klein R; Schmidt F; Weller M; Küker W
    Acta Neurol Scand; 2002 Jun; 105(6):450-3. PubMed ID: 12027834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Membranous glomerulonephritis during primary Gougerot-Sjögren syndrome].
    Laraki R; Chauveau D; Noel LH; Hermine O
    Presse Med; 2005 Sep; 34(15):1069-72. PubMed ID: 16334882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
    J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement].
    Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S
    Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleural Effusion In A Patient With Primary Sjögren's Syndrome Successfully Treated With Corticosteroids.
    Cruz-Pérez Fdel P; Doval-Cortés A; Jaume-Anselmi F; Ramírez-Rivera J
    Bol Asoc Med P R; 2015; 107(3):13-6. PubMed ID: 26742190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuro-Sjögren: A clinical-radiological paradox affecting the central nervous system.
    Villa E; Torres A; Orellana P; de Grazia J; Villanueva ME; Guevara C
    J Neuroimmunol; 2023 May; 378():578085. PubMed ID: 37058850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agranulocytosis in a patient with primary Sjögren's syndrome.
    Petrasovicová V; Pavelka K; Neuwirtová R; Korínková P; Alusík S; Trnavský K
    Clin Rheumatol; 1990 Dec; 9(4):530-4. PubMed ID: 2088651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy.
    Wright RA; O'Duffy JD; Rodriguez M
    Neurology; 1999 Jan; 52(2):386-8. PubMed ID: 9932962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome.
    Konttinen YT; Kinnunen E; von Bonsdorff M; Lillqvist P; Immonen I; Bergroth V; Segerberg-Konttinen M; Friman C
    Arthritis Rheum; 1987 Mar; 30(3):339-44. PubMed ID: 3566825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Sjogren's syndrome with central nervous system involvement.
    Alhomoud IA; Bohlega SA; Alkawi MZ; Alsemari AM; Omer SM; Alsenani FM
    Saudi Med J; 2009 Aug; 30(8):1067-72. PubMed ID: 19668890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.